What is the appropriate dose of drotaverine for a 12‑year‑old girl weighing 50 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Drotaverine Dosing for a 12-Year-Old Female Weighing 50 kg

I cannot provide a definitive dose recommendation for drotaverine in this patient because none of the provided evidence contains pediatric dosing guidelines, drug labels, or clinical trial data for drotaverine in children.

Critical Evidence Gap

The available evidence includes:

  • Adult studies only: The research evidence addresses drotaverine use in adults for renal colic 1 and bioavailability studies in adults aged 20-27 years 2, but provides no pediatric dosing information.

  • No pediatric guidelines: Despite extensive guideline evidence for other medications (oseltamivir, ondansetron, acetaminophen, ibuprofen), there are no guidelines addressing drotaverine use in children 3, 4, 5.

  • No drug label information: The evidence does not include FDA-approved labeling or manufacturer dosing recommendations for drotaverine in pediatric populations.

What the Evidence Does Show

Adult dosing from clinical trials: In adults with renal colic, drotaverine was administered as 80 mg intravenous bolus, with the option to repeat once if necessary 1. However, this cannot be extrapolated to a 12-year-old without appropriate pharmacokinetic and safety data.

Pharmacokinetic considerations: Children aged ≥2 years are pharmacokinetically similar to adults and differ primarily in size, but neonates and infants have immature elimination pathways 6. A 12-year-old would be considered pharmacokinetically mature, but simple weight-based scaling from adult doses (mg/kg) results in inappropriate dosing in children because elimination does not change in direct proportion to weight 6.

Clinical Recommendation

Do not administer drotaverine to this patient without consulting:

  • The manufacturer's prescribing information for pediatric dosing
  • A pediatric pharmacist or clinical pharmacologist
  • Published pediatric pharmacokinetic studies specific to drotaverine

Alternative approach: If the indication is smooth muscle spasm or colicky pain, consider evidence-based pediatric alternatives with established safety profiles and dosing guidelines in this age group.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ondansetron Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Pediatric Acetaminophen and Ibuprofen Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.